Showing results (861-870 of 5,257) with videos related to

Sort By:
Pageof 526
Oncology|July 12, 2005
Increased antitumor activity in combined treatment TS-1 and docetaxel. A preclinical study using gastric cancer xenograftsIkuo Takahashi, Yasunori Emi, Yoshihiro Kakeji, et al.
Oncology|July 12, 2005
An early phase II study of S-1 in patients with metastatic pancreatic cancerHideki Ueno, Takuji Okusaka, Masafumi Ikeda, et al.
Oncology|July 15, 2005
Alterations in connexin26 expression during colorectal carcinogenesisLuiza Kanczuga-Koda, Stanislaw Sulkowski, Mariusz Koda, et al.
Oncology|July 15, 2005
Clinical significance of osteopontin in esophageal squamous cell carcinoma: comparison with common tumor markersYutaka Shimada, Go Watanabe, Junichiro Kawamura, et al.
Oncology|July 16, 2005
Epithelial syndecan-1 expression is associated with stage and grade in colorectal cancerM Lundin, S Nordling, J Lundin, et al.
Oncology|July 16, 2005
Serum lipid profile in colorectal cancer patients with and without synchronous distant metastasesMaria Notarnicola, Donato F Altomare, Mario Correale, et al.
Oncology|July 16, 2005
Weekly docetaxel and gemcitabine as first-line treatment for metastatic breast cancer: results of a multicenter phase II studyS Palmeri, M Vaglica, S Spada, et al.
Oncology|July 16, 2005
Dose-dense sequential adriamycin-Paclitaxel-cyclophosphamide chemotherapy is well tolerated and safe in high-risk early breast cancerZsuzsanna Kahan, Gabriella Uhercsak, Rozalia Hajnal-Papp, et al.
Oncology|July 16, 2005
Leptin is associated with an increased female colorectal cancer risk: a nested case-control study in JapanKoji Tamakoshi, Hideaki Toyoshima, Kenji Wakai, et al.
Oncology|August 30, 2005
Identification of clinical prognostic factors in patients with unknown primary tumors treated with a platinum-based combinationAndrea Piga, Rosaria Gesuita, Vincenzo Catalano, et al.
Pageof 526